When Trump championed the drug this spring, it became a third rail political issue. Though it showed promise for early stage COVID, research faded.
USA TODAY, USA Today: Opinion
Thu, 07/09/2020 - 1:00am
When Trump championed the drug this spring, it became a third rail political issue. Though it showed promise for early stage COVID, research faded.